Home  /  Resource Library  /  Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study

Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study

Study examined quality of life in patients with relapsed CTCL after treatment with Brentuximab Vedotin.